Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab
- Author(s):
- Ridker, P.M.; Tardif, J.C.; Amarenco, P.; Duggan, W.; Glynn, R.J.; Jukema, J.W. (0000-0002-3246-8359); Kastelein, J.J.P.; Kim, A.M.; Koenig, W.; Nissen, S.; Revkin, J.; Rose, L.M.; Santos, R.D.; Schwartz, P.F.; Shear, C.L.; Yunis, C.; SPIRE Investigators
- Published
- 2017
- Publication type
- Article / Letter to editor
- Date issued
- 2017-04-20
- Language
- English
- Is part of
- New England Journal of Medicine (2017), Vol. 376, no. 16, p. 1517-1526
- hdl
- 1887/95095
- doi
- 10.1056/NEJMoa1614062